UK Industry Calls For 'Early & Open' Talks Over ‘Extreme’ 2023 Clawbacks
Executive Summary
The current UK approach to drug pricing and access is "broken," and early talks with the government next year will be necessary to set out a "completely new future settlement," the pharmaceutical industry has warned. By contrast, the government claims that the pricing scheme is working as intended.